The Dementia Tracker Is Officially In the Works

Vice News — In a rare move, the Federal Bureau of Investigation has officially launched a program to develop a device that would detect and track the brains of Dementias.

The DMT-T is a brain-scanning device that could eventually be used in conjunction with the National Dementian Dataset to track Dementiaries’ brains, according to a joint press release by the FBI and the Brain Institute of the Department of Brain and Cognitive Sciences at the University of Michigan. 

The project, called DMT and the National Neuropsychiatric Imaging Resource Center, is being conducted by the Brain Imaging Research Group of the FBI Brain Imaging Laboratory and the Bureau of Alcohol, Tobacco, Firearms and Explosives, and the Office of the National Coordinator for Development and Implementation of the BRAIN Initiative. 

DMT is the first such technology to be developed at the federal level.

According to the Bureau’s press release, “The FBI’s Neuropsychological Imaging Resource Centers (NPIC) are dedicated to developing new, affordable and comprehensive tools to collect and analyze brain imaging data. 

In the past two decades, NNIC has become a leader in developing new and innovative technology that can help law enforcement agencies and private sector organizations collect, analyze and share information about criminal behavior and conduct.” 

The NNICS is an interdisciplinary collaborative effort of researchers, educators, researchers, private industry and government.

The bureau is seeking the participation of individuals, companies and universities to help fund the project. 

“As DMT develops, the bureau’s mission to make the most efficient use of neuroscience will grow,” said John O’Malley, director of the Brain and Cognition Research Institute.

“With the NNIS, we will be able to leverage the vast data sets of the NNI to advance understanding of the brain’s structure and function.” 

As part of the project, a team of FBI neuroscientists will be working on the development of the device, which will be developed using a proprietary, non-invasive method known as diffusion tensor imaging.

This technique has been used to study the brains and brains of schizophrenics and other people with neurological conditions, such as Parkinson’s disease, to better understand how and why their brains change over time. 

Researchers from the Brain Infrastructure Laboratory of the Neural Imaging Research Center at the Brain Research Institute will use the DMT to monitor the brains, as well as the movements of people with dementia, and analyze data from the device’s sensors. 

According to the press release: “DMT will have three primary purposes.

First, the DNT can be used as a test to determine if an individual has dementia, as long as the subject is awake and conscious and has no medical issues or medical interventions that could potentially interfere with the device.

Second, the device will allow the DCT team to determine how a person’s brain is changing, including the level of oxygenation in the brain, and which areas of the cerebral cortex are most active and active in the areas that require the most oxygenation.” 

DNT can also be used to assess the level and direction of brain changes associated with dementia and to evaluate how an individual is functioning with dementia. 

As for the potential application, DMT will be used by law enforcement to identify Dementios, or demented individuals, who are at high risk for developing dementia and may be at greater risk for having a brain injury. 

If the device is used to identify someone with dementia at the time of a crime, the agency will determine whether the person should be taken into custody or taken to a psychiatric hospital. 

Once DMT has been tested, the FBI will collect brain images of those people who are eligible for DMT, and then analyze the data to develop new ways to track the brain and assess the cognitive, psychological and physical health of those individuals. 

Additionally, the project will use DMT’s sensor to track people with disabilities, including those who are blind, deaf, deafened, or have a physical or sensory disability. 

It will also use the sensor to gather data about the cognitive functioning of people who have been diagnosed with a condition known as a chronic condition, which includes the condition of dementia.

These individuals will be tracked in the hope that the device can be paired with behavioral intervention programs that are available to help them. 

To learn more about the FBI’s neuroscience research efforts, please visit the Bureau website: